SF 2238: Relating to prescription drug affordability, including the creation of a prescription drug affordability board

What it does

This bill relates to prescription drug affordability measures, including the creation of a prescription drug affordability board. The bill provides definitions used in the bill. The bill creates the prescription drug affordability board (board) for the purpose of protecting stakeholders within the health care system from the high costs of prescription drug products (product or products). The bill provides for the membership and functioning of the board; the hiring of an executive director and other staff for the board; salaries, per diems, and reimbursement of expenses of the executive director, general counsel, staff, and members; and other provisions that apply to the meetings of the board.

Senate subcommittee · named February 8, 2024

• Sen. Jeff Edler (R)
• Sen. Mark Costello (R) · mark.costello@legis.iowa.gov
• Sen. Molly Donahue (D) · molly.donahue@legis.iowa.gov

Lobbying · 1 for, 3 against

For: Wellmark, Inc.

Against: Healthcare Distribution Alliance; Iowa Biotechnology Association; Pharmaceutical Research and Manufacturers of America (PhRMA)

In plain words

1. February 7, 2024Filed in the Senate and sent to the Health and Human Services committee
2. February 8, 2024Senate subcommittee named: Edler, Costello and Donahue